Guanze Medical Reports No Share Capital Changes in July 2026; Public Float Remains Above 25% Requirement

Bulletin Express08-06

Guanze Medical Information Industry (Holding) Co., Ltd. released its Monthly Return for Equity Issuer for the period ended 31 July 2026, confirming stable share capital metrics and ongoing compliance with Hong Kong’s public float rules.

The authorised share structure remained unchanged at 10.00 billion ordinary shares with a par value of HKD 0.01 each, representing authorised capital of HKD 100.00 million.

Issued share capital also held steady. The company closed the month with 950.00 million issued shares and no treasury shares, identical to the previous month’s figures.

Management affirmed that the public float continues to satisfy the Main Board’s Initial Prescribed Threshold of 25% of issued shares.

The filing disclosed no activity in share options, warrants, convertibles, or other share-issuing agreements during the month, indicating no dilution or capital structure alterations.

The return was signed by Company Secretary Cheng Cheung King and submitted to Hong Kong Exchanges and Clearing Limited on 06 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment